These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9392626)

  • 41. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
    Grif K; Dierich MP; Karch H; Allerberger F
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Shiga toxin-producing Escherichia coli: an overview.
    Gyles CL
    J Anim Sci; 2007 Mar; 85(13 Suppl):E45-62. PubMed ID: 17085726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Production of Shiga-like toxins in viable but nonculturable Escherichia coli O157:H7.
    Liu Y; Wang C; Tyrrell G; Li XF
    Water Res; 2010 Feb; 44(3):711-8. PubMed ID: 19879621
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid Detection of Escherichia coli O157 and Shiga Toxins by Lateral Flow Immunoassays.
    Wang J; Katani R; Li L; Hegde N; Roberts EL; Kapur V; DebRoy C
    Toxins (Basel); 2016 Mar; 8(4):92. PubMed ID: 27023604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
    Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
    FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of a real-time PCR-based system for monitoring of O26, O103, O111, O145 and O157 Shiga toxin-producing Escherichia coli in cattle at slaughter.
    Hofer E; Stephan R; Reist M; Zweifel C
    Zoonoses Public Health; 2012 Sep; 59(6):408-15. PubMed ID: 22348425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic characteristics, virulence profile and genetic relatedness of O157 Shiga toxin-producing Escherichia coli isolated in Brazil and other Latin American countries.
    Bastos FC; Vaz TM; Irino K; Guth BE
    FEMS Microbiol Lett; 2006 Dec; 265(1):89-97. PubMed ID: 17034414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.
    Carey CM; Kostrzynska M; Ojha S; Thompson S
    J Microbiol Methods; 2008 May; 73(2):125-32. PubMed ID: 18328583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dissemination and persistence of Shiga toxin-producing Escherichia coli (STEC) strains on French dairy farms.
    Fremaux B; Raynaud S; Beutin L; Rozand CV
    Vet Microbiol; 2006 Oct; 117(2-4):180-91. PubMed ID: 16837144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Johnson KE; Thorpe CM; Sears CL
    Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The synthesis of a multivalent heterobifunctional ligand for specific interaction with Shiga toxin 2 produced by E. coli O157:H7.
    Jacobson JM; Kitov PI; Bundle DR
    Carbohydr Res; 2013 Aug; 378():4-14. PubMed ID: 23768952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shiga toxin production by sausage-borne Escherichia coli O157:H7 in response to a post-processing in vitro digestion challenge.
    Naim F; Leblanc D; Messier S; Saucier L; Piette G; Houde A
    Food Microbiol; 2006 May; 23(3):231-40. PubMed ID: 16943009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.
    Nishikawa K
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):239-47. PubMed ID: 21644029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic characterization of Escherichia coli O157: H7/- strains carrying the stx2 gene but not producing Shiga toxin 2.
    Koitabashi T; Vuddhakul V; Radu S; Morigaki T; Asai N; Nakaguchi Y; Nishibuchi M
    Microbiol Immunol; 2006; 50(2):135-48. PubMed ID: 16490932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.
    Tarr PI; Gordon CA; Chandler WL
    Lancet; 2005 Mar 19-25; 365(9464):1073-86. PubMed ID: 15781103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.
    Huang J; Motto DG; Bundle DR; Sadler JE
    Blood; 2010 Nov; 116(18):3653-9. PubMed ID: 20644116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman, Argentina.
    Miceli S; Jure MA; de Saab OA; de Castillo MC; Rojas S; de Holgado AP; de Nader OM
    Jpn J Infect Dis; 1999 Apr; 52(2):33-7. PubMed ID: 10816611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.